rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Daniel A. Camardo

Director

Company insider

Files Form 4 as: Director, Cue Biopharma; CEO, Athersys, Inc / New; EVP and President, U.S., Horizon Therapeutics Public Ltd Co.

Every Form 4 they filed

In numbers

Trades disclosed
39
Buys
2
Sells
2
Bought
$157K
Sold
$1.4M
Companies
3
Companies where not an officer
1
First trade
3 Aug 2020
Last trade
9 Jul 2026
Last filed
10 Jul 2026

Companies traded

Where they are an officer
Athersys, Inc / NewDirector, Officer · last 4 Oct 20232 buys · 0 sells
Horizon Therapeutics Public Ltd CoOfficer · last 5 Apr 20210 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CUE Cue BiopharmaDirector · Biotechnology · last 9 Jul 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jul 2026filed 10 Jul 2026CUE Cue BiopharmaBiotechnologySEC FORM 4 Code A—21,800 at $0.00filing
9 Jul 2026filed 10 Jul 2026CUE Cue BiopharmaBiotechnologySEC FORM 4 Code A—21,800 at $0.00filing
30 May 2026filed 8 Jun 2026CUE Cue Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—1,626 at $0.00filing
30 May 2026filed 8 Jun 2026CUE Cue Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—1,626 at $0.00filing
4 Oct 2023filed 6 Oct 2023Athersys, Inc / NewSEC FORM 4 Code F$8,79719,993 at $0.44filing
5 Jul 2023filed 6 Jul 2023Athersys, Inc / NewSEC FORM 4 Code F$18K19,993 at $0.91filing
4 Apr 2023filed 5 Apr 2023Athersys, Inc / NewSEC FORM 4 Code F$20K19,993 at $1.00filing
4 Jan 2023filed 6 Jan 2023Athersys, Inc / NewSEC FORM 4 Code F$20K23,484 at $0.85filing
22 Nov 2022filed 22 Nov 2022Athersys, Inc / NewSEC FORM 4 Bought$55K100,000 at $0.55filing
4 Oct 2022filed 6 Oct 2022Athersys, Inc / NewSEC FORM 4 Code A—263,492 at $0.00filing
17 Mar 2022filed 17 Mar 2022Athersys, Inc / NewSEC FORM 4 Bought$102K132,800 at $0.77filing
14 Feb 2022filed 14 Feb 2022Athersys, Inc / Newoption or derivativeSEC FORM 4 Code A—4,000,000 at $0.00filing
5 Apr 2021filed 5 Apr 2021Horizon Therapeutics Public Ltd CoSEC FORM 4 Code M$40K2,305 at $17.19filing
5 Apr 2021filed 5 Apr 2021Horizon Therapeutics Public Ltd CoSEC FORM 4 Code M$395K15,467 at $25.52filing
5 Apr 2021filed 5 Apr 2021Horizon Therapeutics Public Ltd CoSEC FORM 4 Code M$7,752509 at $15.23filing
5 Apr 2021filed 5 Apr 2021Horizon Therapeutics Public Ltd Cooption or derivativeSEC FORM 4 Code M—2,305 at $0.00filing
5 Apr 2021filed 5 Apr 2021Horizon Therapeutics Public Ltd Cooption or derivativeSEC FORM 4 Code M—15,467 at $0.00filing
5 Apr 2021filed 5 Apr 2021Horizon Therapeutics Public Ltd Cooption or derivativeSEC FORM 4 Code M—509 at $0.00filing
30 Mar 2021filed 31 Mar 2021Horizon Therapeutics Public Ltd CoSEC FORM 4 Sold$151K1,803 at $83.58filing
30 Mar 2021filed 31 Mar 2021Horizon Therapeutics Public Ltd CoSEC FORM 4 Sold$390K4,594 at $84.97filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.